| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/02/2014 | EP2749269A1 Process for the preparation of adsorbates of imatinib |
| 07/02/2014 | EP2749267A1 Anti-malarial pharmaceutical composition |
| 07/02/2014 | EP2749266A1 Stable injectable pharmaceutical composition of vitamin D receptor agonist and process for preparation thereof |
| 07/02/2014 | EP2748614A2 Method of screening for chaperonin modulator |
| 07/02/2014 | EP2748204A1 Cationic peptidopolysaccharides with excellent broad- spectrum antimicrobial activities and high selectivity |
| 07/02/2014 | EP2748172A2 Anti-viral compounds |
| 07/02/2014 | EP2748171A1 Pyrano [3, 2 - d][1, 3]thiazole as glycosidase inhibitors |
| 07/02/2014 | EP2748170A1 1,4-diazabicyclo[3.2.2]nonanes as neuronal nicotinic acetylcholine receptor ligands |
| 07/02/2014 | EP2748169A2 Anti-viral compounds |
| 07/02/2014 | EP2748168A2 Inhibitors of nedd8-activating enzyme |
| 07/02/2014 | EP2748167A1 Hepatitis c inhibitor compounds |
| 07/02/2014 | EP2748166A1 Pyrimido- pyridazinone compounds and use thereof |
| 07/02/2014 | EP2748165A1 1,6- diazabicyclo [3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections |
| 07/02/2014 | EP2748164A1 Bicyclic heteroaromatic compounds |
| 07/02/2014 | EP2748162A1 2 -amino-4 - (pyridin- 2 -yl) - 5, 6 -dihydro-4h- 1, 3 -oxazine derivatives and their use as bace-1 and/or bace - 2 inhibitors |
| 07/02/2014 | EP2748160A1 Hepatitis c inhibitor compounds |
| 07/02/2014 | EP2748159A1 Serine/threonine pak1 inhibitors |
| 07/02/2014 | EP2748158A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals |
| 07/02/2014 | EP2748156A1 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| 07/02/2014 | EP2748149A1 Pyridazinone compounds and their use as daao inhibitors |
| 07/02/2014 | EP2748147A1 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
| 07/02/2014 | EP2748146A1 A crystalline form of the sodium salt of 4-tert-butyl-n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide |
| 07/02/2014 | EP2747772A1 Ophthalmic formulations |
| 07/02/2014 | EP2747771A1 Cyclic oligosaccharides for use in the treatment and prevention of bacterial infection |
| 07/02/2014 | EP2747770A1 Treatments involving eslicarbazepine acetate or eslicarbazepine |
| 07/02/2014 | EP2747769A1 2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use |
| 07/02/2014 | EP2747768A2 Compositions and methods for treating neurodegenerative disease |
| 07/02/2014 | EP2747767A1 Certain chemical entities, compositions, and methods |
| 07/02/2014 | EP2747766A1 Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature |
| 07/02/2014 | EP2747765A1 Compositions and methods for treating viral diseases |
| 07/02/2014 | EP2747764A1 Structural mimetics of proline-rich peptides and use thereof |
| 07/02/2014 | EP2747763A1 (bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders |
| 07/02/2014 | EP2747762A1 Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients |
| 07/02/2014 | EP2747761A1 Methods of treating cancers with therapeutic nanoparticles |
| 07/02/2014 | EP2747760A1 Sterile alginate-based aqueous composition for medical use and process for the preparation thereof |
| 07/02/2014 | EP2747759A2 Compositions and methods for treating neurodegenerative disease |
| 07/02/2014 | EP2747758A1 A device for the transdermal delivery of alkaline compounds that are susceptible to degradation in their free base form |
| 07/02/2014 | EP2747757A1 Methods for treating cardiovascular disorders |
| 07/02/2014 | EP2747756A1 Metabolizable salts and use thereof in diagnostics and therapy |
| 07/02/2014 | EP2747755A1 Cdk9 inhibitors in the treatment of midline carcinoma |
| 07/02/2014 | EP2747754A1 Morphinan-derivatives for treating diabetes and related disorders |
| 07/02/2014 | EP2747750A2 Liposome comprising at least a cholesterol derivative |
| 07/02/2014 | EP2747746A2 Arjunolic acid for increasing the production of sebum |
| 07/02/2014 | EP2747584A1 Epicatechin for alleviating symptoms of allergy |
| 07/02/2014 | EP2747569A1 Combination treatments for hepatitis c |
| 07/02/2014 | EP2747563A1 Compositions and methods thereof for oral administration of drugs |
| 07/02/2014 | EP2747562A1 Estrogen receptor ligands and methods of use thereof |
| 07/02/2014 | EP2747561A1 Treatment of symptoms associated with female gastroparesis |
| 07/02/2014 | EP2747560A1 Compounds and methods |
| 07/02/2014 | CN203677567U 一种硫酸安普霉素预混剂生产装置 A sulfated apramycin premix production plant |
| 07/02/2014 | CN203677363U 可以显示发热状态的退热贴 You can display the status of the cooling paste fever |
| 07/02/2014 | CN103906759A 用于治疗病毒感染的化合物和药物组合物 For compounds for treating viral infections and pharmaceutical compositions |
| 07/02/2014 | CN103906752A 杂芳基取代的吡唑并吡啶及其用作可溶性鸟苷酸环化酶刺激剂的用途 Heteroaryl substituted pyrazolopyridine their use as use of soluble guanylate cyclase stimulant |
| 07/02/2014 | CN103906751A 作为晚期SV40因子（LSF）抑制剂用于治疗癌症的[1,3]二氧杂环戊烯并[4,5-g]喹啉-6(5H)-硫酮和[1,3]二氧杂环戊烯并[4,5-g][1,2,4]三唑并[1,5-a]喹啉衍生物 As late SV40 factor (LSF) inhibitors for the treatment of cancer [1,3] dioxole and [4,5-g] quinoline -6 (5H) - thione and [1,3] dioxole and [4,5-g] [1,2,4] triazolo [1,5-a] quinoline derivatives |
| 07/02/2014 | CN103906750A 作为选择性NK-3受体拮抗剂的新型手性N-酰基-5,6,7,(8-取代的)-四氢-[1,2,4]三唑并[4,3-a]吡嗪、药物组合物、用于NK-3受体介导的疾病中的方法及其手性合成 As novel chiral N- acyl -5,6,7,8 selective NK-3 receptor antagonists, (8-substituted) - tetrahydro - [1,2,4] triazolo [4,3-a ] pyrazine, pharmaceutical compositions for NK-3 receptor mediated diseases and chiral synthesis method |
| 07/02/2014 | CN103906748A 2-氨基-4-(吡啶-2-基)-5,6-二氢-4h-1,3-*嗪衍生物及其作为bace-1和/或bace-2抑制剂的用途 2-amino-4- (pyridin-2-yl) -5,6-dihydro--4h-1,3- * derivatives and their use as bace-1 and / or bace-2 INHIBITORS |
| 07/02/2014 | CN103906747A 卡巴他赛及其中间体的制备方法 Preparation cabazitaxel and its intermediates |
| 07/02/2014 | CN103906746A 用作钠通道调节剂的(4-苯基咪唑-2-基)乙胺衍生物 Used sodium channel modulators (4-phenyl-imidazol-2-yl) ethylamine derivative |
| 07/02/2014 | CN103906745A 用于治疗神经变性疾病的尿苷二磷酸衍生物、组合物和方法 Uridine diphosphate derivatives for the treatment of neurodegenerative disorders, compositions and methods for |
| 07/02/2014 | CN103906744A 新晶型 New polymorphs |
| 07/02/2014 | CN103906742A 硒吩稠合芳族化合物和其制备方法 Selenophene fused aromatic compounds and their preparation |
| 07/02/2014 | CN103906741A 氨烷基取代的n-噻吩基苯甲酰胺衍生物 Aminoalkyl-substituted n- thienyl benzamide derivative |
| 07/02/2014 | CN103906738A 用于治疗趋化因子介导的疾病的新的二取代的3,4-二氨基-3-环丁烯-1,2-二酮化合物 For the treatment of chemokine mediated disease novel 3,4-disubstituted-amino-3-cyclobutene-1,2-dione compound |
| 07/02/2014 | CN103906737A 烷基酰胺基噻唑、含有它的化妆或皮肤学制剂以及它们的克服和预防皮肤的不期望的色素沉着的用途 Alkylamido thiazole, containing its cosmetic or dermatological preparations and their overcoming and preventing undesired skin pigmentation purposes |
| 07/02/2014 | CN103906736A 作为类香草素受体配体的具有被含n-基团取代的苯基基团的被取代的基于吡唑基的羧酰胺和脲衍生物 As vanilloid receptor ligands having a substituted phenyl group containing n- groups substituted pyrazol-based carboxamide group and urea derivatives |
| 07/02/2014 | CN103906735A 新芳基-喹啉衍生物 New aryl - quinoline derivative |
| 07/02/2014 | CN103906734A 被取代的甲磺酰胺衍生物作为类香草素受体配体 A substituted sulfonamide derivatives as vanilloid receptor ligands |
| 07/02/2014 | CN103906733A Trpm8拮抗剂及其在治疗中的用途 Trpm8 antagonists and their use in the treatment of |
| 07/02/2014 | CN103906732A 用作hdac抑制剂的异羟肟酸酯衍生物以及包含所述衍生物的药物组合物 Inhibitors used hdac hydroxamate derivatives and pharmaceutical compositions comprising said derivative |
| 07/02/2014 | CN103906731A 新的氨基酸n-酰化衍生物与二醇的酯、其制备方法及其在化妆品中以及作为药物的用途 The new amino acid derivatives with diols n- acylated esters, their preparation and their use as pharmaceuticals and in cosmetics |
| 07/02/2014 | CN103906730A Parp抑制剂 Parp inhibitors |
| 07/02/2014 | CN103906527A Mrna递送的脂质纳米颗粒组合物和方法 Lipid nanoparticle composition and delivery method Mrna |
| 07/02/2014 | CN103906522A 阿片激动剂化合物和止痛化合物的组合物、剂型以及共给药 Opioid agonist analgesic compounds and compositions of the compounds, the dosage form, and co-administration |
| 07/02/2014 | CN103906521A S-腺苷甲硫氨酸、维生素e和维生素c在预防和治疗心血管功能障碍中的应用 S- adenosylmethionine, vitamin e and vitamin c used in the prevention and treatment of cardiovascular dysfunction in |
| 07/02/2014 | CN103906520A 用于治疗行为和精神病症的鲨肌醇 For the treatment of behavioral and psychiatric disorders shark inositol |
| 07/02/2014 | CN103906519A 关节病治疗剂 Arthropathy therapeutic agent |
| 07/02/2014 | CN103906518A 使用ras拮抗剂的恶性的和非恶性的疾病治疗 Use ras antagonist malignant and non-malignant diseases |
| 07/02/2014 | CN103906517A 与脱氧胆酸及其多晶型物有关的组合物和方法 And deoxycholate and polymorph related compositions and methods |
| 07/02/2014 | CN103906516A 用于增强T细胞介导的免疫应答的β-内酰胺化合物 Β- lactam compounds for enhancing the immune response of T cell-mediated |
| 07/02/2014 | CN103906515A 治疗黏液表皮样癌的方法 Mucoepidermoid cancer treatment method |
| 07/02/2014 | CN103906514A 用于治疗代谢障碍的组合物和方法 Treatment of metabolic disorders compositions and methods for |
| 07/02/2014 | CN103906513A 限制释放型硫辛酸舌递送系统 Restrictions lipoic acid tongue-release delivery system |
| 07/02/2014 | CN103906512A 四环杂环化合物和其治疗病毒疾病的使用方法 Use tetracyclic heterocyclic compounds and their treatment of viral diseases |
| 07/02/2014 | CN103906511A 抗连接蛋白剂用于提高乙酰胆碱酯酶抑制剂的治疗作用的用途 Anti-connexin agents for use acetylcholinesterase inhibitors to improve therapeutic effect |
| 07/02/2014 | CN103906510A 用于处理皮肤的方法和组合物 Method for treating skin and compositions |
| 07/02/2014 | CN103906509A 脑啡肽酶抑制剂 Neprilysin inhibitor |
| 07/02/2014 | CN103906508A 治疗心血管疾病的方法 The method of treating cardiovascular disease |
| 07/02/2014 | CN103906435A 用于促进镁吸收和/或镁保留的组合物 For promoting magnesium absorption and / or retention of the composition of magnesium |
| 07/02/2014 | CN103906431A 含有松柏树脂酸的含水抗微生物组合物 Pine resin acids containing aqueous antimicrobial compositions |
| 07/02/2014 | CN103898119A 一种多西紫杉醇的核酸适配体、核酸适配体衍生物及其用途 A multi-docetaxel aptamers, aptamers derivatives and their use |
| 07/02/2014 | CN103897206A N,o-羧甲基化壳聚糖-多醛基透明质酸凝胶及其用途 N, o- carboxymethyl chitosan - more aldehyde hyaluronic acid gel and its use |
| 07/02/2014 | CN103897178A 含有蒽环类抗生素结构的新化合物以及制备方法和用途 The new compounds and preparation method and use containing anthracycline structure |
| 07/02/2014 | CN103897177A 蒽环类抗生素偶联非线性多嵌段共聚物及其制备方法和应用 Anthracyclines coupled nonlinear multi-block copolymer and its preparation method and application |
| 07/02/2014 | CN103897176A 蒽环类抗生素偶联非线性多嵌段共聚物及其制备方法和应用 Anthracyclines coupled nonlinear multi-block copolymer and its preparation method and application |
| 07/02/2014 | CN103897175A 含有蒽环类抗生素结构的新化合物以及制备方法和用途 The new compounds and preparation method and use containing anthracycline structure |
| 07/02/2014 | CN103897174A 含有利尿酸结构的新聚合物以及制备方法和用途 The new polymers and preparation and use structures containing uric acid |
| 07/02/2014 | CN103897173A 含有多柔比星结构的非线性聚合物以及制备方法和用途 Nonlinear polymer containing doxorubicin and preparation method and use the star structure |
| 07/02/2014 | CN103897117A 一种两亲季铵内盐及其制备方法与应用 Ammonium salt in the preparation method and application of a amphiphilic quaternary |
| 07/02/2014 | CN103897072A 一种金刚藤多糖提取物及其制备方法 One kind Jingangteng polysaccharide extract and its preparation method |
| 07/02/2014 | CN103897043A 一种穿膜多肽连接拉帕替尼的制备及应用 A penetrating peptides connection preparation and application lapatinib |